NPC submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the notice, “Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, Including the Hospital Inpatient Quality Reporting Program; Health and Safety Standards for Obstetrical Services in Hospitals and Critical Access Hospitals; Prior Authorization; Requests for Information; Medicaid and CHIP Continuous Eligibility; Medicaid Clinic Services Four Walls Exceptions; Individuals Currently or Formerly in Custody of Penal Authorities; Revision to Medicare Special Enrollment Period for Formerly Incarcerated Individuals; and All-Inclusive Rate Add-On Payment for High-Cost Drugs Provided by Indian Health Service and Tribal Facilities (CMS-1809-P).”
NPC's comments address several important areas, including:
- Cell and Gene Therapy Payment Policies
- Efforts to Expand Access to High-Cost Drugs Provided by Indian Health Services and Tribal Facilities
- Patient Access to Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Infection Prevention
- Modifications to the Packaging Policy for Diagnostic Radiopharmaceuticals
- Collection of Patient-Reported Outcomes Measures and Social Drivers of Health Data